Search Results
Nov 05, 2025, 07:00 ET AKTIS ONCOLOGY APPOINTS KYLE KUVALANKA CHIEF FINANCIAL OFFICER
"Kyle is a proven leader with deep expertise in biopharmaceutical finance, business development, and corporate affairs," said Matthew Roden, PhD, President and Chief Executive Officer of Aktis Oncology. "He has raised over $700 million in capital and has led numerous transactions to build and
More news about: Aktis Oncology
Nov 05, 2025, 06:00 ET Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy
by industry veteran Chris Viehbacher as Chair, joined by Jasper Bos, PhD; Erez Chimovits, MBA, MSc; Jason Coloma, PhD, MBA; Tim Lohoff, PhD; David Malek, MBA; and Travis Murdoch, MD. Board Observers include Vineeta Agarwala, MD, PhD; Evan Caplan, MBA, MD; and Neel Varshney, MD. "Braveheart
More news about: Braveheart Bio
Nov 05, 2025, 05:27 ET AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES FIRST BRIDGE FUNDING AWARDS TO SUSTAIN CRITICAL PARKINSON'S RESEARCH
support. "This program reflects APDA's deep commitment to the scientists behind the breakthroughs," said Rebecca Gilbert, MD, PhD, Chief Mission Officer, APDA. "When researchers face abrupt funding losses, their critical work, and sometimes their careers, can be derailed. We acted
More news about: American Parkinson Disease Association, Inc.
Nov 05, 2025, 05:00 ET XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development
regulatory, and commercial milestone payments, is up to $345 million. "Lilly has been a long-time partner of ours," said Jian Ma, PhD, CEO and co-founder of XtalPi. "We are proud to see Lilly expand this trusted relationship into the biologics space, recognizing the potential of our
More news about: XtalPi Inc.
Nov 04, 2025, 18:31 ET QS Asia University Rankings 2026
India sangat unggul dalam hal produktivitas penelitian dan staf dengan gelar PhD Malaysia adalah salah satu sistem pendidikan tinggi terbaik dalam edisi ini.
More news about: QS Quacquarelli Symonds
Nov 04, 2025, 16:25 ET Eilean Therapeutics Presents First-in-Class MALT1 Degrader TE205 Demonstrating In Vivo Efficacy in Ulcerative Colitis at the 4th International Conference on Microbiology and Immunology
www.eileanther.com. Media Contact: Amy Burd, PhD Chief Scientific OfficerEilean Therapeutics LLC
More news about: Eilean Therapeutics
Nov 04, 2025, 16:01 ET Inhibrx Announces Participation in Upcoming Scientific Conferences
Presentation Presenters: Josep Garcia, PhD, Executive Vice President, Chief Clinical Development Officer, Inhibrx; Katelyn Willis, PhD, Director, Biotherapeutics, Inhibrx Date:
More news about: Inhibrx Biosciences, Inc.
Nov 04, 2025, 15:07 ET AllOne Health Releases Largest-Ever Study of EAP Work/Life Services, Analyzing 59,000+ Real-World Cases
embedded Work/Life services, we can connect them to consultants, resources, and referrals in many important areas," shares study lead author Mark Attridge, PhD. "This approach aligns with behavioral health best practices—early intervention, ease of access, and continuity of care—all of which reduce barriers
More news about: AllOne Health
Nov 04, 2025, 12:00 ET RO TO PRESENT EIGHT RESEARCH ABSTRACTS AT OBESITYWEEK 2025
alongside two expert developers of the RAID-FN scale, David B. Allison, PhD, Professor of Pediatrics and Endowed Chair and Director of USDA-ARS Children's Nutrition Research Center at Baylor College of Medicine and Emily Dhurandar, PhD, Director of Research Special Projects at Texas Tech University Health
More news about: Ro
Nov 04, 2025, 11:26 ET QS Asia University Rankings 2026
भारत शोध उत्पादकता और PhD प्राप्त कर्मचारियों के लिए आकर्षक बन रहा है। इस संस्करण में मलेशिया सर्वाधिक उन्नत उच्च शिक्षा सिस्टमों में से एक है।
More news about: QS Quacquarelli Symonds
Nov 04, 2025, 10:17 ET PPMD Provides $400,000 in Funding to MyoGene Bio Through PPMD Venture Pathways Program to Support Development of Gene Editing Platform
therapy forward. Through PPMD Venture Pathways, we can help usher in yet another approach for treating patients with Duchenne," explains Eric Camino, PhD, PPMD's Vice President of Research and Clinical Innovation. "Gene editing represents a strategy to make life-long corrections to variants in patients'
More news about: Parent Project Muscular Dystrophy (PPMD)
Nov 04, 2025, 09:47 ET People Science and Phynova Launch Chloe LiveLab, A New Collaborative Ingredient-Brand Research Model to Generate Real-World Evidence
Research "Chloe LiveLab bridges the gap between RCTs and real-world consumers," said Belinda Tan, MD, PhD, Co-CEO and Co-Founder of People Science. "It turns research into a shared experience between suppliers, brands, and consumers. This is the next generation
More news about: People Science, Inc.
Nov 04, 2025, 09:15 ET State-of-the-Art "Drone Innovation Center" Set to Open on Full Sail University's Campus
entertainment media education and on-campus facilities to further incorporate the use, research, and study of drone technology," stated Haifa Maamar, PhD, Executive Director of Emerging Technologies at Full Sail University. This technology is used across numerous sectors that our students and graduates
More news about: Full Sail University
Nov 04, 2025, 09:02 ET Phenomix Sciences Expands Evidence for MyPhenome™ Test Predicting GLP-1 Response and Obesity Risk in Large, Diverse Populations
The studies, led by Mayo Clinic researcher and Phenomix co-founder Andres Acosta, MD, PhD, further validate the MyPhenome test's ability to predict patient response to GLP-1 therapies such as semaglutide and provide early insight
More news about: Phenomix Sciences
Nov 04, 2025, 09:00 ET Abbott HeartMates Community Delivers Holiday Cheer in Hallmark Channel's New Movie "The More the Merrier"
https://www.heart.org/-/media/PHD-Files-2/Science-News/2/2024-Heart-and-Stroke-Stat-Update/2024-Statistics-At-A-Glance-final_2024.pdf
More news about: Abbott
Nov 04, 2025, 08:45 ET Chandigarh University Secures 1st Rank among Private Universities in India for 3rd Consecutive Year in QS Asia University Rankings 2026
Academic Reputation, Faculty Student Ratio, Outbound Exchange Students, Inbound Exchange Students, Papers per Faculty, Citations per Paper and Staff with PhD. Overall, Chandigarh University improved its score for most performance indicators. While Chandigarh University secured 1st
More news about: Chandigarh University
Nov 04, 2025, 08:32 ET iLeukon Receives FDA Clearance of IND Application for A Phase II Study of mRNA-based non-alpha IL-2 variant, ILKN421H, in Advanced Non-Small Cell Lung Cancer (NSCLC)
B-cell lymphomas. Media Contacts Brandon Nadres, PhD Product Development ManageriLeukon [email protected]
More news about: iLeukon Therapeutics
Nov 04, 2025, 08:30 ET MiDOG Expands Scientific Advisory Board with the Appointment of Dr. Curtis Huttenhower, Dr. Micah Kohles, and Dr. Krista A. Keller
Nov. 4, 2025 /PRNewswire/ -- MiDOG Animal Diagnostics is proud to announce the appointment of Dr. Curtis Huttenhower, PhD, Dr. Micah B. Kohles, DVM, MPA, and Dr. Krista A. Keller, DVM, Dipl. ACZM to its Board of Directors and Scientific Advisory Board. Together, these experts
More news about: MiDOG Animal Diagnostics
Nov 04, 2025, 08:30 ET Ensuring compliance with animal-free raw materials in CGT, Upcoming Webinar Hosted by Xtalks
Novo Nordisk Pharmatech A/S, Sara Bursomanno, PhD, Senior Global Product Manager; and Chantale Julien, Global Product Manager, for the live webinar on Thursday, November 20, 2025, at 10am EST (4pm CET/EU-Central).
More news about: Xtalks
Nov 04, 2025, 08:00 ET Bugcrowd Acquires Mayhem Security to Bring Human-Augmented AI Automation to Security Testing
Dr. Thanassis Avgerinos, two world-renowned cybersecurity innovators who each hold a PhD from Carnegie Mellon University. United by a vision to transform how organizations find and fix vulnerabilities, they've built a platform that blends
More news about: Bugcrowd
Nov 04, 2025, 07:00 ET Magnet Biomedicine Appoints Bharat Reddy, Ph.D., as Chief Business Officer
multimedia:https://www.prnewswire.com/news-releases/magnet-biomedicine-appoints-bharat-reddy-phd-as-chief-business-officer-302602874.html
More news about: Magnet Biomedicine
Nov 04, 2025, 07:00 ET Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
Samarendra Mohanty, PhD, President and Chief Scientific Officer of Nanoscope. "The absence of serious safety signals and strong participant retention underscore the potential
More news about: Nanoscope Therapeutics
Nov 04, 2025, 07:00 ET Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
Samarendra Mohanty, PhD, President and Chief Scientific Officer of Nanoscope. "The absence of serious safety signals and strong participant retention underscore the potential
More news about: Nanoscope Therapeutics
Nov 04, 2025, 06:45 ET SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
SOPHiA GENETICS, with revenue growth accelerating for a third consecutive quarter to 23% as new business continues to come online," said Jurgi Camblong, PhD., Chief Executive Officer and Co-founder. "We also demonstrated strong operating leverage as platform scalability and rigorous cost discipline resulted
More news about: SOPHiA GENETICS
Nov 04, 2025, 05:00 ET 'The Gaslit Brain' Exposes Global Leadership Crisis Fueled by Manipulation and Lies
from the Lies of Bullying, Gaslighting, and Institutional Complicity by award-winning Canadian educator and bestselling author Dr. Jennifer Fraser, PhD, is the first book to directly link gaslighting — infecting governments, bedrooms, workplaces and institutions worldwide — to measurable neurological
More news about: The Bullied Brain